Tuesday, January 9, 2024
processing....
30% of Cancer Deaths Linked to Smoking; Over-the-Counter Birth Control; and HIV and Premature Aging
Slow Progress, but Many Disparities in Cancer Burden Persist
Chicago Oncologist Charged With Insider Trading
New Trials in GI Cancers: Could Your Patient Benefit?
New Trials in Non-CRC GI Cancers: Could Your Patient Benefit?
Going All In: Two Aggressive Cancers, One Surgical Team Who's Not Giving Up
FDA OKs First-Line Pembrolizumab With Chemo for Gastric/GEJ Cancer
COMMENTARY
Going All In: Two Aggressive Cancers, One Surgical Team Who's Not Giving Up
Jeffrey B. Teitler, MFA
DisclosuresDecember 14, 2023
Surgeons know not to count on miracles, but sometimes they can happen. Our cameras follow a surgical team as they work together to treat a patient with an uncertain outcome.
Follow Medscape on Facebook, X (formerly known as Twitter), Instagram, and YouTube
Medscape Oncology © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Going All In: Two Aggressive Cancers, One Surgical Team Who's Not Giving Up - Medscape - Dec 14, 2023.
Tables
Authors and Disclosures
Authors and Disclosures
Author
Jeffrey B. Teitler, MFA
Professor, Department of Communication, Central Connecticut State University, New Britain, Connecticut; Director, Envision Films, West Hartford, Connecticut
Disclosure: Jeffrey B. Teitler, MFA, has disclosed no relevant financial relationships.